METHOD FOR DIFFERENTIAL DIAGNOSING OF PANCREATIC DISEASES Russian patent published in 2020 - IPC A61B5/00 G01N33/74 G01N33/574 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to oncology, surgery, and can be used for differential diagnostics of pancreatic diseases. At the stage of examination in the blood of a patient with pancreatic disease by immunophenotyping, content of dehydroepiandrosterone-sulphate – DHEA-S and 17-oxyprogesterone – 17-OHP is determined. If the level of DHEA-S=2.4±0.2 and 17-OHP=0.42±0.40 patient is diagnosed with pancreatic neuroendocrine tumor. If DHEA-S=3.7±0.37 and 17-OHP=1.9±0.19 is diagnosed with pancreatic adenocarcinoma. If the level of DHEA-S=6.42±0.69 and 17-OHP=2.8±0.32 is diagnosed with chronic pancreatitis.

EFFECT: method enables differential diagnostics of pancreatic diseases at the stages of primary examination by determining the content of DHEA-S and 17-oxyprogesterone – 17-OHP by immunophenotyping.

1 cl, 1 tbl, 3 ex